Keyphrases
Huntington's Disease
100%
18F-fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET)
71%
Plaque Inflammation
66%
Carotid Plaque
66%
Ischemic Stroke
66%
Metabolic
42%
Brain Function
41%
Carotid Atherosclerosis
40%
Apathy
38%
Metabolic Changes
38%
Premanifest
33%
Cerebrospinal Fluid Biomarkers
33%
Recurrent Stroke
33%
Early Recurrent Stroke
33%
18F-florbetapir
33%
Lumipulse
33%
Amyloid Positron Emission Tomography
33%
Plaque Vulnerability
33%
Soluble Intercellular Adhesion molecule-1 (sICAM-1)
33%
Positron Emission Tomography
33%
Oxidized Low-density Lipoprotein (ox-LDL)
33%
LDL Cholesterol
33%
Brain Correlates
33%
Electronegative LDL
33%
Stenosis
33%
Pre-manifest
33%
Brain Structure
33%
Alzheimer's Disease
33%
Dissociation
33%
Bilingualism
33%
Malignant Melanoma
33%
Stroke Recurrence
26%
Florbetapir Positron Emission Tomography
25%
SUVmax
23%
Blood Samples
23%
Logistic Regression Analysis
23%
Thromboembolic Stroke
23%
Plaque
21%
Carotid Stenosis
21%
Metabolism
19%
Neurodegeneration
17%
Regression Analysis
17%
G System
16%
Carotid Plaque Vulnerability
16%
Modified LDL
16%
CT Angiography
16%
Phosphorylated tau
16%
Total tau
16%
Vulnerable Atherosclerotic Plaque
16%
Healthy Controls
16%
Medicine and Dentistry
Huntington's Disease
100%
Fluorodeoxyglucose F 18
84%
Positron Emission Tomography
77%
Biological Marker
71%
Apoplexy
66%
Bilingualism
33%
Cerebrospinal Fluid
33%
Alzheimer's Disease
33%
Brain Ischemia
33%
Immunotherapy
33%
Intercellular Adhesion Molecule 1
33%
Melanoma
33%
Amyloid Protein
33%
Recurrent Disease
32%
Gray Matter
28%
Florbetapir (18F)
19%
Polyethylene Terephthalate
18%
Basal Ganglia
14%
Neurodegeneration
13%
Positron Emission Tomography-Computed Tomography
12%
Hazard Ratio
10%
Cognitive Reserve
9%
Inferior Frontal Gyrus
9%
Brain Metabolism
9%
Side Effect
9%
Stereotypic Movement Disorder
9%
Neurologic Disease
9%
Standardized Uptake Value
8%
Prospective Study
5%
Linear Regression Analysis
5%
Carotid Atherosclerosis
5%
Logistic Regression Analysis
5%
Fractalkine
5%
Proportional Hazards Model
5%
Internal Carotid Artery
5%
Cell Adhesion Proteins
5%
Atherosclerosis
5%
Carotid Disease
5%
Neuroscience
Huntington's Disease
100%
Fluorine-18
70%
Brain Ischemia
66%
Blood Plasma
55%
Positron Emission Tomography
36%
Stenosis
33%
Immunotherapy
33%
Intercellular Adhesion Molecule 1
33%
Cerebrovascular Accident
33%
Treatment-Resistant Schizophrenia
33%
Deep Brain Stimulation
33%
Metabolic Pathway
31%
Anterior Cingulate Cortex
25%
Oxidized Low Density Lipoprotein
22%
Nucleus Accumbens
20%
Gray Matter Volume
15%
Gray Matter
14%
Basal Ganglia
14%
Prefrontal Cortex
12%
Positron Emission Tomography
11%
High Density Lipoprotein Cholesterol
11%
Apolipoprotein B
11%
1 Alkyl 2 Acetylglycerophosphocholine Esterase
11%
Antioxidant
11%
Angiography
11%
Low Density Lipoprotein Cholesterol
11%
Inferior Frontal Gyrus
11%
Aryldialkylphosphatase 1
11%
Enzyme Activity
11%
Neurodegeneration
9%
Stereotypic Movement Disorder
9%
Brain Metabolism
9%
Positron Emission Tomography-Computed Tomography
9%
Computed Tomography
9%
Dorsolateral Prefrontal Cortex
6%
Electroencephalogram
6%
Hippocampus
6%
Mental Disorder
6%
Thalamus
6%
Nervous System Disorder
6%
Caudate Nucleus
6%
Internal Carotid Artery
5%
Fractalkine
5%
Neuroprotective Agent
5%
Cell Adhesion Proteins
5%
